Kronos Bio Inc Share Price

NASDAQ: KRON

$0.88

+0.01

(+1.49%)

as on June 20, 2025 at 7:08 pm IST

$₹

The stock has been delisted from the stock exchange on 20 Jun 2025

Kronos Bio Inc Stock Performance

as on June 20, 2025 at 7:08 pm IST

$0.88
Day's Price Range
$0.88
$0.88
52 Week's Low
52 Week's High
$0.65
52-Week Price Range
$1.09
$0.88
26.14%
Downside
23.86%
Upside

Kronos Bio Inc share price movements today

Previous Close: $0.87
Open: $0.88
Volume: 400.0
Day's Low - High: $0.88 - $0.88
52 Week Low - High: $0.65 - $1.09

Kronos Bio Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Kronos Bio Inc Stock Fundamentals & Key Indicators

Check Kronos Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

0.00%

Kronos Bio Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Kronos Bio Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Kronos Bio Inc	BUY	$-	NA	NA	0.00%

Analyst Recommendation on Kronos Bio Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Kronos Bio Inc. Average target price of $2.25

Kronos Bio Inc Share Price Target

Get share price movements and forecasts by analysts on Kronos Bio Inc.

What analysts predicted

60.89%UPSIDE

Target Price

$2.25

Current Price

$0.88

Analyzed by

9 Analysts

Target

$2.25

Kronos Bio Inc target price $2.25, a slight upside of 60.89% compared to current price of $0.88. According to 9 analysts rating.

Kronos Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	-	1	1	0	2	2	2	2	2	1
Gross Profit	-1	0	0	0	1	1	2	2	2	1
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-29	-23	-29	-31	-25	-29	-16	-14	-25	-8
Net Profit Margin	0.00%	-1917.61%	-1595.55%	-3421.37%	-1107.61%	-1188.81%	-602.68%	-595.27%	-1137.14%	-448.71%

Kronos Bio Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	3	6	9
Gross Profit	0	0	-4	-4	-4	6	9
Operating Income	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-6	-15	-64	-149	-129	-112	-86
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-4192.38%	-1791.87%	-874.08%

Global Institutional Holdings in Kronos Bio Inc

Funds	Holdings
Vida Ventures Advisors, LLC	4.54%
Vanguard Group Inc	3.15%
PARTNERS CAPITAL INVESTMENT GROUP, LLP	2.38%
Alphabet Inc	2.36%
Millennium Management LLC	2.34%

See all

About Kronos Bio Inc

Kronos Bio, Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases. Its product candidates include KB-9558 and KB-7898. KB-9558, which inhibits the lysine acetyltransferase (KAT) domain of p300, a critical node of the IRF4 TRN, is in preclinical development for the treatment of multiple myeloma and human papillomavirus (HPV)-driven tumors. IRF4 is a key transcription factor driver in multiple myeloma and KB-9558 selectively targets its activity. KB-7898 is a p300 KAT inhibitor for the treatment of Sjogren’s disease, a chronic autoimmune disease that is characterized by the production of autoantibodies, chronic inflammation and lymphocytic infiltration of the exocrine glands that lead to uncomfortable dryness symptoms, known as sicca.

Organisation	Kronos Bio Inc
E-voting on shares	Click here to vote

FAQs

What is Kronos Bio Inc share price today?

Kronos Bio Inc share price today is $0.88 as on June 20, 2025 at 7:08 pm IST at the close of the market. Kronos Bio Inc share today touched a day high of $0.88 and a low of $0.88.

What is the 52 week high and 52 week low for Kronos Bio Inc share?

Kronos Bio Inc share touched a 52 week high of $1.09 on January 23, 2025 and a 52 week low of $0.65 on May 15, 2025. Kronos Bio Inc stock price today i.e. June 20, 2025 at 7:08 pm IST is closed at $0.88,which is 19.27% down from its 52 week high and 35.38% up from its 52 week low.

How to invest in Kronos Bio Inc Stock (KRON) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kronos Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kronos Bio Inc Shares that will get you 1.7045 shares as per Kronos Bio Inc share price of $0.88 per share as on June 20, 2025 at 7:08 pm IST.

What is the minimum amount required to buy Kronos Bio Inc Stock (KRON) from India?

Indian investors can start investing in Kronos Bio Inc (KRON) shares with as little as ₹88.27 or $1 (as of September 15, 2025 at 10:48 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Kronos Bio Inc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 10:48 am IST). Based on Kronos Bio Inc share’s latest price of $0.88 as on June 20, 2025 at 7:08 pm IST, you will get 11.3636 shares of Kronos Bio Inc. Learn more about fractional shares .